HIGHLIGHTS
20,952,179 Placement Shares will be issued pursuant to the Company’s placement capacity under Listing Rule 7.1 and 13,554,863 Placement Shares will be issued pursuant to the Company’s placement capacity under Listing Rule 7.1A.
The issue price of $0.071 represents a 0% discount to the last trading price of $0.071 on 15 October 2024 and a premium of 3% to the 15-day volume weighted average price of $0.069.
Funds from the Placement will be directed towards exploration activities at the Company’s Ulytau Uranium Project and working capital.
The Company has engaged ARQ Capital Pty Ltd (Lead Manager) to manage the Placement. The Lead Manager (or its nominees) will receive a capital raising fee of 6% on the amount raised under the Placement, a management fee of $15,000 and 2,500,000 options with an exercise price of $0.115 expiring 12 December 2025 (Broker Options), the issue of the Broker Options is subject to shareholder approval at the Company’s upcoming AGM.
The Company has approved the issue of 4,000,000 Director Incentive Options (Director Options) to be issued to the Director (or their nominee), the issue of the Director Options is subject to shareholder approval at the Company’s upcoming AGM. The Director Options have an exercise price of $0.110 expiring three years from date of issue. The allocation of the Director Options is as follows, Mr Shannon Green to be issued 2,000,000 Director Options, Mr Jamie Myers to be issued 1,500,000 Director Options and Mr David Lees to be issued with 500,000 Director Options.
Leave a Reply